Around the web ×1
Quick answers
Did Mingjie Xie co-found Rapid Novor?
Yes. Rapid Novor's about page, checked September 23, 2026, lists "Mingjie Xie, Co-founder and CEO" alongside "Qixin Liu, Co-founder and CTO" and co-founder and chief scientist Dr. Bin Ma, and says the company was founded in 2015 by three people.
What is his role at Rapid Novor today?
Chief executive. The company's about page, checked September 23, 2026, gives his title as "Co-founder and CEO", and Rapid Novor's April 7, 2026 PRWeb release on its Princess Margaret Cancer Centre EasyM study names him as the company's media contact.
What has Rapid Novor done under him?
The University of Waterloo's David Johnston Research + Technology Park reported on July 31, 2020 that Rapid Novor had closed a "$5 million USD" Series A and quoted Xie, as "Founder and CEO", saying "there is currently no other technology available to directly sequence and profile antibody proteins from blood." Communitech's reprint of a May 27, 2021 company release quotes him calling it "the first time in the world that animal polyclonal antibodies have been de novo sequenced successfully purely from protein."
Is Rapid Novor still operating?
Yes. Rapid Novor announced on March 10, 2026 that its diagnostic laboratory had received a provisional licence from the Ontario Ministry of Health for its EasyM multiple myeloma blood test, and on April 7, 2026 that patient enrolment was complete in a Princess Margaret Cancer Centre study of EasyM.